+1 862-686-2696

  • Ready-to-Use Models. Faster Immunotherapy Research. | Save Up to 25%

    Learn More
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Cell Culture Media, Kits & Reagents
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Transfected Stable Cell Lines

Xpress™ Human GPC3 Over-expressing Cell Line (EL4)

  • For research use only

Cat No.

ABC-X0419C
Product Type

Overexpression Stable Cell Lines
Cell Type

T lymphocyte
Species

Human
Host Cell

EL4
Source Organ

Thymus
Disease

Lymphoma
Storage

Liquid Nitrogen

EL4 cells with human GPC3 overexpression, designed for tumor immunology studies, therapeutic target screening, and T cell engagement assays.

Product Image
  • Xpress™ Human GPC3 Over-expressing Cell Line (EL4)
Get a Quote
Home | Transfected Stable Cell Lines | Overexpression Stable Cell Lines | Xpress™ Human GPC3 Over-expressing Cell Line (EL4)

Description

GPC3 antibody research focuses on detecting and targeting glypican-3 (GPC3), a cell-surface heparan sulfate proteoglycan associated with hepatocellular carcinoma (HCC). GPC3 has been investigated as a biomarker and therapeutic target in liver cancer, making antibody-binding specificity and assay validation important considerations in target characterization and antibody screening. The Xpress™ Human GPC3 Over-expressing Cell Line (EL4) is a murine EL4 T-lymphoma cell model engineered to express human GPC3. According to the product specifications, GPC3 overexpression is validated at the gene level by quantitative reverse-transcription PCR (qRT-PCR). This model may support studies of GPC3 antibody binding, target recognition, and candidate binding-reagent screening in cell-based assays. However, gene-level validation does not independently establish cell-surface protein abundance or antibody-binding performance. This model retains a murine cellular background and should not be used as a substitute for a human hepatocellular carcinoma cell model. Antibody-binding experiments should include parental EL4 cells or an appropriate GPC3-negative control to distinguish GPC3-specific binding from background signals, and cell-surface GPC3 expression should be confirmed using a suitable protein-level assay.

Species

Human
Cat.No

ABC-X0419C
Product Category

Transfected Stable Cell Lines
Size/Quantity

1 vial
Cell Type

T lymphocyte
Growth Mode

Suspension
Shipping Info

Dry Ice
Growth Conditions

37 °C, 5% CO2
Source Organ

Thymus
Disease

Lymphoma
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Overexpression Stable Cell Lines
Host Cell

EL4
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Xpress™ Human GPC3 Over-expressing Cell Line (EL4) may be used in GPC3 antibody research, particularly for evaluating target recognition, comparing candidate binding reagents, and investigating antibody-binding specificity in cell-based assays. Flow cytometry may be suitable for assessing cell-surface binding, while immunofluorescence or other appropriate protein-detection methods can provide complementary evidence of GPC3 expression. Parental EL4 cells or other suitable negative controls can help researchers assess background binding and distinguish GPC3-associated signals from nonspecific interactions. Because the host is a murine T-lymphoma cell line expressing human GPC3, this model is primarily suited to target-binding studies rather than assumed immune-function evaluation. Its suitability for functional immune-cell assays or target-occupancy studies must be established separately according to the antibody’s mechanism of action and the experimental design. Product-specific protein expression and assay performance should be independently confirmed where required.

Area of Interest

Glypican-3 is a cell-surface proteoglycan investigated as a biomarker and therapeutic target in hepatocellular carcinoma. Research on GPC3-directed antibodies has explored target recognition and therapeutic strategies, including conformation-specific antibodies designed to recognize cell-surface GPC3. The Xpress™ Human GPC3 Over-expressing Cell Line (EL4) provides an engineered model for investigating human GPC3 in a murine cellular background. Relevant research areas include antibody-binding specificity, comparative target recognition, screening of GPC3-binding reagents, and evaluation of binding signals under controlled assay conditions. Since the product specifications report gene-level validation, researchers should independently confirm GPC3 protein expression and cell-surface accessibility before using the model for antibody-binding experiments. Results should also be interpreted in light of the murine host background and should not be assumed to reproduce endogenous GPC3 expression or the tumor microenvironment of human HCC. Published studies on GPC3-directed antibodies provide scientific context but do not independently validate this specific AcceGen cell line.

Workflow Stages

Experimental Planning (Define the GPC3 antibody-binding or target-recognition objective.) → Cell Recovery (Thaw and recover the EL4-derived overexpression cells according to the supplier’s protocol.) → Cell Culture (Maintain cells under the supplier-recommended culture conditions.) → Expression Verification (Confirm GPC3 protein expression and, where relevant, cell-surface localization using a suitable assay.) → Control Preparation (Include parental EL4 cells or other appropriate negative controls where available.) → Antibody Incubation (Incubate cells with the GPC3 antibody or candidate binding reagent under validated conditions.) → Signal Detection (Measure binding using flow cytometry or another assay compatible with the antibody and detection system.) → Data Analysis (Compare signals from GPC3-expressing cells and controls to evaluate relative binding specificity.) → Result Interpretation (Consider protein expression, background binding, antibody cross-reactivity, and assay limitations.)

  • Online Inquiry
  • Product Reviews

Inquiring Xpress™ Human GPC3 Over-expressing Cell Line (EL4)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button